Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...

Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.

Kristen Gryskevich, 51, found weight to be a struggle throughout her life, but when she gave birth to her two boys in 2001 ...

Eli Lilly ( LLY 2.92%) and Novo Nordisk ( NVO -0.89%) were early leaders in the development of GLP-1 agonists, and dominate the market. Research from MarketsandMarkets suggests that annual global ...

Cryptocurrency exchange FTX has disqualified approximately 392,000 customer claims after users failed to verify their identities by the March 3 deadline, potentially nullifying claims exceeding $2.5 ...

Learn how and where to inject Zepbound and where to get additional help. Plus, get tips for injecting the drug at home and ...

A three-acre Los Altos property recently hit the market with an $8 million price tag. That's not hugely different from other ...

The Children’s Museum of Atlanta received a $2.5 million grant to help them create a new program for character development.

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are tirzepatide (Zepbound) and semaglutide (Wegovy). Semaglutide was originally ...

Pfizer was also developing a twice-daily formulation of the drug, which showed promising weight loss, but was plagued by ...

US Stock Market Highlights: US markets tumbled Thursday after the White House confirmed a 145% tariff rate on Chinese goods. The Dow plunged over 2,100 points intraday before recovering partially amid ...